Favipiravir
|
- $5 - $2000
- Product name: Favipiravir
- CAS: 259793-96-9
- MF: C5H4FN3O2
- MW: 157.1
- EINECS:1533716-785-6
- MDL Number:MFCD12032148
- Synonyms:Pyrazinecarboxamide, 6-fluoro-3,4-dihydro-3-oxo- (9CI);Favipiravir;Unii-ew5gl2X7E0;6-fluoro-3,4-dihydro-3-oxo- (9CI);PYRAZINECARBOXAMIDE, 6-FLUORO-3,4-DIHYDRO-3-OXO-;2-PyrazinecarboxaMide, 6-fluoro-3,4-dihydro-3-oxo-;6-Fluoro-3-oxo-3,4-dihydropyrazine-2-carboxaMide;PyrazinecarboxaMide, 6-fl...
35 prices
Selected condition：
Brand
- AK Scientific
- Ambeed
- American Custom Chemicals Corporation
- ApexBio Technology
- Axon Medchem
- Biorbyt Ltd
- Cayman Chemical
- Chemenu
- ChemScene
- DC Chemicals
- Medical Isotopes, Inc.
- Tocris
- TRC
- Usbiological
Package
- 1mg
- 5MG
- 10mg
- 25mg
- 50mg
- 100mg
- 250mg
- 1g
- 5g
- 10g
- 25g
- 50
- 100g
- ManufacturerAK Scientific
- Product numberW4933
- Product descriptionFavipiravir
- Packaging250mg
- Price$401
- Updated2021-12-16
- Buy
- ManufacturerAmbeed
- Product numberA265413
- Product description6-Fluoro-3-oxo-3,4-dihydropyrazine-2-carboxamide 99+%
- Packaging50mg
- Price$5
- Updated2021-12-16
- Buy
- ManufacturerAmbeed
- Product numberA265413
- Product description6-Fluoro-3-oxo-3,4-dihydropyrazine-2-carboxamide 99+%
- Packaging100mg
- Price$7
- Updated2021-12-16
- Buy
- ManufacturerAmbeed
- Product numberA265413
- Product description6-Fluoro-3-oxo-3,4-dihydropyrazine-2-carboxamide 99+%
- Packaging250mg
- Price$10
- Updated2021-12-16
- Buy
- ManufacturerAmbeed
- Product numberA265413
- Product description6-Fluoro-3-oxo-3,4-dihydropyrazine-2-carboxamide 99+%
- Packaging1g
- Price$17
- Updated2021-12-16
- Buy
- ManufacturerAmbeed
- Product numberA265413
- Product description6-Fluoro-3-oxo-3,4-dihydropyrazine-2-carboxamide 99+%
- Packaging5g
- Price$40
- Updated2021-12-16
- Buy
- ManufacturerAmbeed
- Product numberA265413
- Product description6-Fluoro-3-oxo-3,4-dihydropyrazine-2-carboxamide 99+%
- Packaging25g
- Price$108
- Updated2021-12-16
- Buy
- ManufacturerAmbeed
- Product numberA265413
- Product description6-Fluoro-3-oxo-3,4-dihydropyrazine-2-carboxamide 99+%
- Packaging100g
- Price$340
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberAPI0008132
- Product descriptionFAVIPIRAVIR 95.00%
- Packaging5MG
- Price$496.72
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberAPI0008132
- Product descriptionFAVIPIRAVIR 95.00%
- Packaging1G
- Price$865.2
- Updated2021-12-16
- Buy
- ManufacturerApexBio Technology
- Product numberB1114
- Product descriptionT705
- Packaging25mg
- Price$280
- Updated2021-12-16
- Buy
- ManufacturerAxon Medchem
- Product numberAxon3135
- Product descriptionFavipiravir-T-705 99%
- Packaging50mg
- Price$154
- Updated2021-12-16
- Buy
- ManufacturerBiorbyt Ltd
- Product numberorb146260
- Product descriptionFavipiravir (T-705) >98%
- Packaging1g
- Price$1802
- Updated2021-12-16
- Buy
- ManufacturerBiorbyt Ltd
- Product numberorb146260
- Product descriptionFavipiravir (T-705) >98%
- Packaging250mg
- Price$912.9
- Updated2021-12-16
- Buy
- ManufacturerBiorbyt Ltd
- Product numberorb146260
- Product descriptionFavipiravir (T-705) >98%
- Packaging100mg
- Price$542.3
- Updated2021-12-16
- Buy
- ManufacturerCayman Chemical
- Product number23384
- Product descriptionT-705 ≥98%
- Packaging100mg
- Price$117
- Updated2024-03-01
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| AK Scientific | W4933 | Favipiravir | 250mg | $401 | 2021-12-16 | Buy |
| Ambeed | A265413 | 6-Fluoro-3-oxo-3,4-dihydropyrazine-2-carboxamide 99+% | 50mg | $5 | 2021-12-16 | Buy |
| Ambeed | A265413 | 6-Fluoro-3-oxo-3,4-dihydropyrazine-2-carboxamide 99+% | 100mg | $7 | 2021-12-16 | Buy |
| Ambeed | A265413 | 6-Fluoro-3-oxo-3,4-dihydropyrazine-2-carboxamide 99+% | 250mg | $10 | 2021-12-16 | Buy |
| Ambeed | A265413 | 6-Fluoro-3-oxo-3,4-dihydropyrazine-2-carboxamide 99+% | 1g | $17 | 2021-12-16 | Buy |
| Ambeed | A265413 | 6-Fluoro-3-oxo-3,4-dihydropyrazine-2-carboxamide 99+% | 5g | $40 | 2021-12-16 | Buy |
| Ambeed | A265413 | 6-Fluoro-3-oxo-3,4-dihydropyrazine-2-carboxamide 99+% | 25g | $108 | 2021-12-16 | Buy |
| Ambeed | A265413 | 6-Fluoro-3-oxo-3,4-dihydropyrazine-2-carboxamide 99+% | 100g | $340 | 2021-12-16 | Buy |
| American Custom Chemicals Corporation | API0008132 | FAVIPIRAVIR 95.00% | 5MG | $496.72 | 2021-12-16 | Buy |
| American Custom Chemicals Corporation | API0008132 | FAVIPIRAVIR 95.00% | 1G | $865.2 | 2021-12-16 | Buy |
| ApexBio Technology | B1114 | T705 | 25mg | $280 | 2021-12-16 | Buy |
| Axon Medchem | Axon3135 | Favipiravir-T-705 99% | 50mg | $154 | 2021-12-16 | Buy |
| Biorbyt Ltd | orb146260 | Favipiravir (T-705) >98% | 1g | $1802 | 2021-12-16 | Buy |
| Biorbyt Ltd | orb146260 | Favipiravir (T-705) >98% | 250mg | $912.9 | 2021-12-16 | Buy |
| Biorbyt Ltd | orb146260 | Favipiravir (T-705) >98% | 100mg | $542.3 | 2021-12-16 | Buy |
| Cayman Chemical | 23384 | T-705 ≥98% | 100mg | $117 | 2024-03-01 | Buy |
Properties
Melting point :>151°C (dec.)
Density :1.78±0.1 g/cm3(Predicted)
storage temp. :under inert gas (nitrogen or Argon) at 2-8°C
solubility :Soluble in DMSO (30 mg/mL), water (12 mg/mL with warming)
form :solid
pka :8.77±0.60(Predicted)
color :Off-white
Stability :Stable for 1 year from date of purchase as supplied. Solutions in DMSO or water may be stored at -20° for up to 3 months.
Density :1.78±0.1 g/cm3(Predicted)
storage temp. :under inert gas (nitrogen or Argon) at 2-8°C
solubility :Soluble in DMSO (30 mg/mL), water (12 mg/mL with warming)
form :solid
pka :8.77±0.60(Predicted)
color :Off-white
Stability :Stable for 1 year from date of purchase as supplied. Solutions in DMSO or water may be stored at -20° for up to 3 months.
Safety Information
| Symbol(GHS): |
|
||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal word: | Warning | ||||||||||||||
| Hazard statements: |
|
||||||||||||||
| Precautionary statements: |
|
Description
Favipiravir is a new broad-spectrum antiviral drug targeting RNA-dependent RNA polymerase (RdRp) developed by Japan's Toyama Chemical Pharmaceutical Company. It was approved for marketing in Japan in March 2014 for the treatment of new and recurrent influenza. During the outbreak of the new coronavirus, the results of the Phase I clinical study of the drug published in March 2020 showed that the drug may have the effect of speeding up virus clearance to alleviate the progress of new coronavirus pneumonia.More related product prices
6-Fluoro-1H-indole-4-carboxylic acid methyl ester 116293-90-4 Velpatasvir 57226-68-3 AZ20 METHOPRENE ACIDRelated product price
- 6-Fluoro-1H-indole-4-carboxylic acid methyl ester
$26-6519 - 116293-90-4
$65-2989 - Velpatasvir
$9-1500
Suppliers and manufacturers
CONIER CHEM AND PHARMA LIMITED
HEBEI Meijinnong Import And Export Trade Co.,LTD
